Get started

G-money

NIFTY forms triangle pattern! Check out where it could breakout.Nifty - Technical Analysis: -Nifty ended flat today, after opening above 11550 it made lower highs forming a triangle pattern -Closed at 11535, breakout to be seen from the triangle on Friday -The markets traded with lacklustre volumes with no definite direction. If we need to see higher levels, we need to cross the resistance of 11600 Market - Driving Factors: -Among sectors, buying witnessed in the IT, pharma, auto and FMCG pack, while bank and metal remained under pressure. -Bharti Infratel, Grasim Industries, Titan Company, UPL and Wipro were among major gainers on the Nifty, -While Top losers were: Bharti Airtel, ICICI Bank, Hindalco Industries, Axis Bank and Kotak Mahindra Bank -30-34 Companies have received approvals for initial public offerings (IPOs) totalling around Rs 33,500 crore would be hitting the market soon. Nifty - Outlook for Friday, 4th September: NIFTY formed a descending triangle pattern in 1hr charts. If the lower base of the triangle breaks, then the trendline might be tested again. A breakout above the triangle will lead to resistance zone and crossing above 11600 could see higher levels towards 12000.
NSE:NIFTY
by Algokart
1
BSV - Is it going higher or will it retrace?Remember about a week ago, I drew those lines. Like I always say be prepared for both scenarios. There are only two scenarios Up or Down. Find a management system that allows you to profit from both scenarios. I bought at the dip and sold 25% at the current prices. I think It will retrace to 170$, I could be wrong but I am okay because my system allows me to manage my positions and if i miss something, I'll be able to get it next time. Trade with probability not feelings. The only time feelings come in play is, 'Is majority having the same feelings as me?'. If yes, do the opposite, if no maintain course. haha. 1% of people make money in the markets, so that is the thought processes.
B
by JacobTrader100
NUTANIX Stock AnalysisQuote: #NTNX Buy Target: $39.45 Sell Target: $42-$45 Panic/Exit price in case of decline and risk of being trapped= $35.00 Description: Nutanix, Inc., together with its subsidiaries, develops and provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. Its solution addresses a range of workloads, including enterprise applications, databases, virtual desktop infrastructure, unified communications, and big data analytics. The company offers Acropolis, an open platform comprising hyper-convergence, native virtualization, enterprise storage, virtual networking, and platform services; and Prism, an end-to-end consumer-grade management plane providing management and analytics across its software products and services. Next earnings: 05/23/2019 (NASDAQ estimate) Short Interest: Short Percent of Float 6.12 % Short % Increase / Decrease -9 % Analyst ratings: Stock Price Target NTNX High $63.00 Median $48.50 Low $25.00 Average $46.80 Current Price $39.02 March - 22 - 19 Reiterated Maxim Group Buy $62 --- $58 March - 11 - 19 Upgrade Jefferies Hold --- Buy $42 Mar-04-19 Downgrade Raymond James Outperform --- Mkt Perform Mar-01-19 Reiterated Needham Buy $76 --- $63 Mar-01-19 Reiterated Maxim Group Buy $72 --- $62 Mar-01-19 Reiterated BofA/Merrill Buy $63 --- $51 Mar-01-19 Downgrade Wells Fargo Outperform --- Market Perform $70 --- $45 Mar-01-19 Downgrade Stifel Buy --- Hold $55 --- $39 Jan-16-19 Upgrade Morgan Stanley Equal-Weight --- Overweight Please Follow us on our Social Media. Please Subscribe to our newsletter to get the analysis directly to your mail. Facebook - @SFYBUofficial Twitter - @SFYBUofficial
NASDAQ:NTNXLong
by SFYBUofficial
ImmunoPrecise Antibodies Stock AnalysisQuote: #IPA/#IPATF Buy Target:$0.80/$0.60 (don’t bet the house here looking for a quick scalp) Sell Target: $1.00 Description: ImmunoPrecise Antibodies Ltd. engages in antibody production and related services in the United States, Canada, and Europe. It also provides human antibody development, hybridoma development, genetic immunization, rabbit monoclonal antibody development, recombinant protein expression and production, cryostorage, hybridoma sequencing, antibody generation, antibody purification, polyclonal development, and peptide production services. The company has a collaboration agreement with TetraGenetics, Inc. The company was founded in 1989 and is based in Victoria, Canada. Please follow us on our facebook and twitter. Subscribe to our newsletter to get analysis directly to your mail. Facebook - @SFYBUofficial Twitter - @SFYBUoffical
ILong
by SFYBUofficial
IMAX Stock analysis long termCompany: Imax Quote: #IMAX Buy Target: TBD pending on price action and tapes into earnings Sell Target: $28-$30 Next Earnings date: April 26th This Is a 20% gainer we missed last Q from being to conservative we will be looking for an entry ether before or after earnings all pending on the tape such a small float it will be a good read reading the tapes into Friday to see which way this name is going to trade. Description: IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company that specializes in motion picture technologies and presentations worldwide. It offers cinematic solution comprising proprietary software, theater architecture, and equipment. The company engages in Digital Re-Mastering (DMR) of films into the IMAX format for exhibition in the IMAX theater network; the provision of IMAX premium theater systems to exhibitor customers through sales, long-term leases, and joint revenue sharing arrangements; the distribution of documentary films; the provision of production technical support and film post-production services; the ownership and operation of IMAX theaters; and the provision of camera and other miscellaneous items rental services. It also designs, manufactures, installs, sells, and leases IMAX theater projection system equipment; maintains IMAX theater projection system equipment in the IMAX theater network; distributes and licenses original content investment, IMAX home entertainment, and others; and sells or leases its theater systems to theme parks, private home theaters, tourist destination sites, fairs, and expositions, as well as engages in the after-market sale of projection system parts and 3D glasses. The company markets its theater systems through a direct sales force and marketing staff. It owns or otherwise has rights to trademarks and trade names, which include IMAX, IMAX Dome, IMAX 3D, IMAX 3D Dome, Experience It in IMAX, The IMAX Experience, An IMAX Experience, An IMAX 3DExperience, IMAX DMR, DMR, IMAX nXos, IMAX think big, think big, and IMAX Is Believing, as well as the service mark IMAX THEATRE. As of December 31, 2018, the company had a network of 1,505 IMAX theater systems comprising 1,409 commercial multiplexes, 14 commercial destinations, and 82 institutional facilities operating in 80 countries. IMAX Corporation was founded in 1967 and is headquartered in Mississauga, Canada. Short Interest: Short Percent of Float 5.86% Short percent of increase or Decrease -4% Analysis Ratings : Stock price Target #IMAX High : $34 Median : $27 Low : $21.50 Average : $27.04 Current Price : $25.33 Feb 25 - 19 Downgrade Canaccord Genuity Buy - Hold $23 Apr 25 - 19 Upgrade The Benchmark Company Hold - Buy $28 Feb 28 - 18 Reiterated B. Riley FBR, INC. Buy $35-$37.75 Tapes last week: 3/5 wouldve gotten a one however the last two days were very bullish Please our Facebook and Twitter for more updates.Please subscribe to our Newsletter for more information Facebook - @SFYBUofficial Twitter - @SFYBUofficial
NYSE:IMAXLong
by SFYBUofficial